R4 · free executive summary
Inside the Nuclear Fuel Cycle
Executive summary · free edition · September 2026
The full report runs to thirteen sections with nine markers we re-score every quarter. This summary is complete in itself and contains the finding. Nothing is held back to make you buy the report.
The uranium price on your screen is a price almost nobody transacts at.
Between the first quarter of 2024 and the first quarter of 2025, the average spot uranium price fell 29.8%. Over the same twelve months, Cameco's realised price — what the largest Western producer actually received per pound — rose 8.7%.
Both numbers come from Cameco's own filings. Nothing changed about its business. Spot moved, and the realised price did not follow, because they are different instruments.
Producers sell most of their production years forward, under contracts with floors and ceilings. Their revenue tracks the long-term contract price, not the spot price. Across ten quarters, Cameco's realised price held between 71.7% and 77.9% of the term price. Its relationship to spot ranged from 61.0% to 94.5% — four times less stable.
Two of the world's largest producers, filing to different regulators in different currencies, landed thirty-six cents apart on realised price over six quarters. Both received about 74% of the term price.
And two governments have now measured the same thing independently. American utilities reported paying US$55.91 a pound under long-term contracts in 2025, against a spot channel at US$75.83. European buyers reported US$54.70 against spot at US$70.33. The price at which roughly 90% of Western uranium physically changed hands was about fifty-five dollars, while the screen said seventy-five.
The producers publish their own collar, and they disagree about it completely.
Cameco discloses that if spot doubled from US$80 to US$160, its 2026 realised price would move from US$66 to US$69. It captures 3.8% of a doubling. Kazatomprom's equivalent table, same date and same grid, captures 31.2% — and has no floor at all.
One sold its upside to buy a floor. The other sold its floor to buy upside. Both tables are public documents. We have not seen the comparison published anywhere else.
If you bought a nuclear or uranium fund, you mostly own a claim on the term price, not the spot price in the headlines.
To be fair to the issuers: every one of them discloses its mandate plainly. These funds are not mis-sold. They are mis-bought.
The gap has no fixed sign. For four of the last ten years, Cameco realised more than spot — 166.8% in 2017. The crossover was 2021.
So we are not claiming producers always get less than spot. We are claiming something more durable and less convenient: realised price is a slow-moving average of past contract prices, spot is a fast-moving price of a thin residual market, and they are different instruments. The gap can open either way.
The full report names nine markers with thresholds and re-scores them every quarter in public. The one that matters most: if realised prices move outside 70–80% of the term price for two consecutive periods across more than one producer, the central claim is wrong. We will say so in that quarter's re-score rather than the one after.
Disclosures. Impersonal research, identical for every purchaser and tailored to no one; not individualised advice, and Finnacl Research is not an investment adviser (publisher's exclusion, Advisers Act §202(a)(11)(D)). The tiers differ in seats and redistribution rights, not in content. No statement about what any reader should hold, no recommended allocation, no forecast. The author holds no position in any company covered in this report. No issuer payment, no advertising, no trading against published views, and no trade in any security named here in the thirty days before or after publication. Full disclosures in §13 of the report.